Myeloperoxidase genetic polymorphisms modulate human neutrophil enzyme activity: genetic determinants for atherosclerosis?
Since MPO is suspected to be a bio-marker in cardiovascular disease, -638C>A and V53F polymorphisms associated with increased enzymatic activity could be genetic determinants for cardiovascular disease risk.
Actual OPS codes are inappropriate for identifying relevant cost-separating factors in the therapy of psychiatric in-patients. They cannot assure in their actual form the standards given by the PsychPV and need substantial revision.